HORIZON PHARMA PLC's ticker is HZNPXXXX and the CUSIP is G4617B105. A total of 185 filers reported holding HORIZON PHARMA PLC in Q4 2017. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $0 | – | 0 | – | 0.00% | – |
| Q1 2021 | $0 | – | 0 | – | 0.00% | – |
| Q4 2020 | $0 | – | 0 | – | 0.00% | – |
| Q3 2020 | $0 | – | 0 | – | 0.00% | – |
| Q2 2020 | $0 | – | 0 | – | 0.00% | – |
| Q1 2020 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
| Q4 2018 | $5,000 | -80.0% | 233 | -82.1% | 0.00% | -100.0% |
| Q3 2018 | $25,000 | – | 1,301 | +7127.8% | 0.00% | – |
| Q2 2018 | $0 | -100.0% | 18 | -82.0% | 0.00% | – |
| Q3 2017 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q2 2017 | $1,000 | -96.6% | 100 | -94.9% | 0.00% | -100.0% |
| Q1 2017 | $29,000 | -9.4% | 1,945 | -2.2% | 0.00% | -50.0% |
| Q4 2016 | $32,000 | -11.1% | 1,989 | -0.3% | 0.00% | 0.0% |
| Q3 2016 | $36,000 | -56.6% | 1,995 | -60.3% | 0.00% | -60.0% |
| Q2 2016 | $83,000 | +62.7% | 5,028 | +111.6% | 0.01% | +66.7% |
| Q4 2015 | $51,000 | – | 2,376 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,609,894 | $109,460,000 | 3.84% |
| Avoro Capital Advisors LLC | 5,593,683 | $92,631,000 | 3.57% |
| Broadfin Capital, LLC | 1,339,575 | $22,183,000 | 3.49% |
| SCOPIA CAPITAL MANAGEMENT LP | 11,912,290 | $197,268,000 | 3.45% |
| JW Asset Management, LLC | 270,775 | $4,484,000 | 2.86% |
| Rhenman & Partners Asset Management AB | 1,632,212 | $27,029,000 | 2.77% |
| Paulson & Co. | 7,670,700 | $127,027,000 | 2.60% |
| Redwood Investments, LLC | 1,315,149 | $21,779,000 | 1.50% |
| KOPP INVESTMENT ADVISORS LLC | 93,220 | $1,544,000 | 1.45% |
| 1492 Capital Management LLC | 72,951 | $1,208,000 | 0.86% |